Naclof Unidose (Diclofenac Sodium)

Diclofenac Sodium, the active ingredient in Naclof Unidose, is a nonsteroidal anti‑inflammatory drug (NSAID) presented as an ophthalmic solution for ocular use. It is employed to reduce inflammation and pain following eye surgery and in other inflammatory eye conditions. The formulation is designed for topical instillation into the conjunctival sac, providing localized anti‑inflammatory activity with minimal systemic exposure.

GNH USA supplies Naclof Unidose as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and offers regulatory‑compliant shipping to meet the needs of global eye‑care providers.

Diclofenac sodium ophthalmic solution is indicated for ocular conditions involving inflammation and pain.

- Post‑operative ocular inflammation: reduces swelling and redness after eye surgery. - Post‑operative ocular pain: provides analgesic relief following cataract or other intraocular procedures. - Allergic conjunctivitis: helps control inflammatory symptoms such as itching and hyperemia.

Ocular administration of diclofenac sodium may be associated with a range of adverse reactions, varying from mild irritation to rare serious events.

Common Side Effects: - Burning or stinging sensation upon instillation - Transient blurred vision - Foreign body sensation - Conjunctival hyperemia - Increased tearing - Mild eyelid edema

Serious or Rare Side Effects: - Corneal ulceration or epithelial defect - Severe allergic reaction including angioedema - Stevens‑Johnson syndrome or toxic epidermal necrolysis - Ocular infection or worsening inflammation - Significant increase in intra‑ocular pressure

Before using Naclof Unidose, consider the following precautions to ensure safe and effective therapy.

- Allergy assessment: avoid if known hypersensitivity to diclofenac, other NSAIDs, or excipients. - Pregnancy and lactation: use only if clearly indicated after risk‑benefit evaluation by a physician. - Contact lens wearers: remove lenses before instillation and wait before reinserting. - Concurrent ocular infections: evaluate and treat infection prior to NSAID use. - Systemic NSAID use: monitor for additive systemic adverse effects. - Store at ambient temperature: keep in original container, protect from light and moisture.

Diclofenac sodium eye drops can interact with other medications, influencing efficacy or safety.

Major Interactions (Avoid): - Systemic NSAIDs: concurrent use may increase risk of systemic adverse events such as gastrointestinal bleeding. - Anticoagulants (e.g., warfarin): may potentiate bleeding tendencies, especially after ocular surgery.

Moderate Interactions (Monitor Closely): - Topical corticosteroids: may affect wound healing when used together. - Beta‑blocker eye drops: monitor intra‑ocular pressure as NSAIDs can alter pressure dynamics. - Other ophthalmic NSAIDs: avoid duplication to prevent excess exposure.